Human infections caused by glycopeptide-resistant Enterococcus spp: Are they a zoonosis?

Clinical Microbiology and Infection

Volumn 7, Issue SUPPL. 4, 2001, Pages 16-33

  Sundsfjord, A ^a,b   Skov Simonsen, G ^b   Courvalin, P ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Enterococcus; Glycopeptide; Resistance; Zoonosis

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; APRAMYCIN; AVOPARCIN; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GROWTH PROMOTOR; NOURSEOTHRICIN; ORIENTICIN A; OXYTETRACYCLINE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; STREPTOGRAMIN; STREPTOMYCIN; STREPTOTHRICIN; SULFONAMIDE; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN; VIRGINIAMYCIN;

ANIMAL HUSBANDRY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DRUG EFFICACY; ENTEROCOCCUS; ERADICATION THERAPY; GENERAL PRACTITIONER; GENETIC RESISTANCE; HUMAN; INFORMATION PROCESSING; MEDICAL DECISION MAKING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; ZOONOSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; ENTEROCOCCUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0035747079     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2001.00055.x     Document Type: Article

References (181)

1. Vancomycin-resistant enterococci
2. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
3. High-level vancomycin-resistant enterococci causing hospital infections
4. Emergence of vancomycin-resistant enterococci in New York City
5. Genotypic characterization of a nosocomial outbreak of vanA Enterococcus faecalis
6. Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden
7. Emergence of vancomycin-resistant enterococci in South Africa
8. Vancomycin-resistant enterococci (VRE) in Canada - Results of the Canadian nosocomial infection surveillance program 1996 VRE point prevalence surveillance project
9. Emergence of vancomycin-resistant enterococci in Australia: Phenotypic and genotypic characteristics of isolates
10. Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: Persistence of multiple species and multiple clones
11. vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: Effect on interpretation of clonality
12. The first clinical isolates of Enterococcus faecium with the VanA phenotype in a tertiary Greek hospital
13. Molecular analysis of vanA elements from strains of Enterococcus faecium and Enterococcus faecalis isolated during the first outbreak of glycopeptide resistant enterococci in Brazil
14. Antimicrobial resistance among enterococci: A view from US clinical laboratories
15. Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid
16. Antimicrobial susceptibility patterns of enterococci causing infections in Europe
17. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium
18. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NTCT 12201 to Staphylococcus aureus
19. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147
20. In vitro conjugative transfer of VanA vancomycin resistance between Enterococci and Listeriae of different species
21. vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum
22. Vancomycin-resistant Bacillus circulans carrying the vanA gene responsible for vancomycin resistance in enterococci
23. Emergence of vancomycin resistance in the genus Streptococcus: Characterization of a vanB transferable determinant in Streptococcus bovis
24. Vancomycin-resistant enterococci outside the health-care setting: Prevalence, sources, and public health implications
25. Medical consequences of antibiotic use in agriculture
26. Glycopeptide-resistant enterococci. A decade of experience
27. Spread of vancomycin-resistant enterococci: Why did it happen in the United States?
28. Spread of vancomycin-resistant enterococci: Differences between the United States and Europe
29. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe
30. Vancomycin resistance: Status quo and quo vadis
31. Epidemiology of resistance to antibiotics. Links between animals and humans
32. Occurrence, selection and spread of resistance to antimicrobial agents used for growth promotion for food animals in Denmark
33. Episome-mediated transfer of drug resistance in Enterobacteriaceae. I. Transfer of resistance factors by conjugation
34. Resistance to penicillins and its transfer in Enterobacteriaceæ
35. Drug resistance and its transfer in Salmonella typhimurium
36. Antimicrobial drugs in animal feeds
37. Report of the joint committee on the use of antibiotics in animal husbandry and veterinary medicine
38. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104
39. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine
40. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-98
41. Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man
42. Inter- and intraspecies spread of Escherichia coli in a farm environment in the abscence of antibiotic usage
43. Spread of plasmid-mediated noursethricin resistance due to antibiotic use in animal husbandry
44. The spread of plasmids as a function of bacterial adaptability
45. High genetic homology between plasmids of human and animal origins conferring resistance to the aminoglycosides gentamicin and apramycin
46. Characterization of a new enterococcal gene, sat G encoding a putative acetyltransferase conferring resistance to streptogramin A compounds
47. Surveillance of antimicrobial resistance in bacteria isolated from food animals to growth promoters and related therapeutic agents in Denmark
48. Presence of the satA gene encoding streptogramin A resistance in Enterococcus faecium from pigs and broilers
49. Antimicrobial resistance in enterococci isolated from turkey flocks fed with virginiamycin
50. Evidence for an animal origin of vancomycin-resistant enterococci
51. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides
52. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infections in man
53. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry
54. vanA-mediated vancomycin-resistant Enterococcus spp. in sewage
55. Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and faecal samples of humans in the community
56. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms
57. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the vanA cluster
58. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms
59. The use of avoparcin as a growth promoter and the occurrence of vancomycin-resistant Enterococcus species in Norwegian poultry and swine production
60. Isolation of glycopeptide-resistant enterococci from chickens in Japan
61. Antimicrobial resistance on pig faecal samples from the Netherlands (five abattoirs) and Sweden
62. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States
63. Historical yearly usage of glycopeptides for animals and humans: The American-European paradox revisited
64. Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin
65. Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban
66. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry
67. Continuing high prevalence of VanA-type vancomycin-resistant enterococci on Norwegian poultry farms three years after avoparcin was banned
68. Persistence of vancomycin-resistant enterococci (VRE) on Norwegian broiler farms
69. Persistence of tetracycline resistance in pig E. coli
70. Influence of oral glycopeptides on the fecal flora of human volunteers: Selection of highly glycopeptide-resistant enterococci
71. Faecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in community in The Netherlands
72. Near absence of vancomycin-resistant enterococci but high carriage rates of quinolone-resistant ampicillin-resistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden
73. Vancomycin-resistant enterococci in turkeys and farmers
74. Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub) urban residents in the south of The Netherlands: Evidence for transmission from animals to humans?
75. Fecal colonization with vancomycin-resistant enterococci in Australia
76. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients
77. Vancomycin-resistant enterococci at a large University hospital in Denmark
78. Colonization by vancomycin-resistant enterococci of the intestinal tract of patients in intensive care units from French general hospitals
79. Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France
80. Prevalence and determinants of fecal colonization with vancomycin-resistant Enterococcus in hospitalized patients in The Netherlands
81. VRE and meat
82. Vancomycin-resistant enterococci in vegetarians
83. A low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients
84. Enterococci resistant to multiple antimicrobial agents including vancomycin. Establishment of endemicity in a University medical center
85. Epidemiological evaluation of antimicrobial resistance in community-acquired enterococci
86. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin
87. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model
88. Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci
89. Isolation of vancomycin resistant Enterococcus faecium from food
90. Characterization of glycopeptide-resistant Enterococcus faecium (GRE) from broilers and pigs in Denmark: Genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides
91. Incidence and relationship of group D streptococci with other indicator organisms in meat
92. Nosocomial enterococci resistance to heat and sodium hypochlorite
93. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces
94. Antibiotic resistant strains of Enterococcus isolated from Swedish retailed chicken and pork
95. Probiotics as a source of Enterococcus Faecium
96. 'Enterococci in food fermentations. Functional and safety aspects'. A European Commission shared cost research project funded within the fair program
97. Presence of vancomycin-resistant enterococci in farm and pet animals
98. Vancomycin-resistant enterococci in cats and dogs
99. Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms
100. Vancomycin-resistant Enterococcus faecium strains with highly similar pulsed-field gel electrophoresis patterns containing similar Tn1546-like elements isolated from a hospitalized patient and pigs in Denmark
101. Intestinal colonization of a human subject by vancomycin-resistant Enterococcus faecium
102. Ingestion of vancomycin-resistant Enterococcus faecium strains of food animal origin by human healthy volunteers: A randomized double-blind study
103. Characterization and identification of Enterococcus species isolated from the intestines of animals
104. Phenotypic identification of the genus Enterococcus and differentiation of phylogenetically distinct enterococcal species and species groups
105. Host specificity of vancomycin-resistant Enterococcus faecium
106. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium
107. Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in VanA isolates
108. Arrangements of the vanA gene cluster in enterococci of different ecological origin
109. Identification and characterization of IS1476, an insertion sequence-like element that disrupts VanY function in a vancomycin-resistant Enterococcus faecium strain
110. Molecular analysis of Tn1546 in Enterococcus faecium isolates from animals and humans
111. Diversity of VanA glycopeptide resistance elements in enterococci from humans and non-human sources
112. Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in the Netherlands
113. Typeability of Tn1546-like elements in vancomycin-resistant enterococci using long-range PCRs and specific analysis of polymorphic regions
114. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from northeastern United States
115. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals
116. DNA sequence variation within vanA, vanB, vanC-1, and vanC-2/3 genes of clinical Enterococcus isolates
117. Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins
118. Investigation by long PCR of the genetic elements mediating VanA glycopeptide resistance in enterococci from uncooked meat in South Manchester
119. Long PCRs of transposons in the structural analysis of genes encoding acquired glycopeptide resistance in enterococci
120. Molecular analysis of diverse elements mediating VanA glycopeptide resistance in enterococci
121. Nucleotide sequence of IS1542, an insertion sequence identified within VanA glycopeptide resistance elements of enterococci
122. Differences in the occurrence of two base pair variants of Tn1546 from vancomycin-resistant enterococci from humans, pigs, and poultry
123. Heterogeneity in the vanB gene cluster of genomically diverse clinical strains of vancomycin-resistant enterococci
124. Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering
125. Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms
126. Analysis of genes encoding D-alanine: D-alanine ligase-related enzymes in Leuconostoc mesenteroides and Lactobacillus spp
127. Evolution of structure and substrate specificity in D-alanine: D-alanine ligases and related enzymes
128. A-alanyl-D-lactate and D-alanyl-D-alanine synthesis by D-alanyl-D-alanine ligase from vancomycin resistant Leuconostoc mesenteroides. Effects of a phenylalanine 216 to tyrosine mutation
129. D-Ala-D-Ala ligases from glycopeptide producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB
130. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms
131. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin resistant VanB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus Leuconostoc mesenteroides, and Enterococcus gallinarum
132. Antibiotic preparations contain DNA. A source of drug resistance genes?
133. DNA sequence resembling vanA and vanB in the vancomycin resistant biopesticide Bacillus popilliae
134. The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal vanA vancomycin resistance gene cluster
135. Genetic characterization of vanG, a novel vancomycin resistance locus of Enterococcus faecalis
136. Nosocomial enterococci resistant to vancomycin - United States, 1989-93
137. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci
138. Characterization of glycopeptide-resistant enterococci from US hospitals
139. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
140. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers
141. Outpatient prevalence of vancomycin-resistant enterococcal (VRE) colonization in the catchment area of a hospital hyperendemic for VRE
142. Patients' endogenous flora as a source of 'nosocomial' vancomycin-resistant enterococci (VRE)
143. Vancomycin resistance and avoparcin
144. Assessing the evidence that antibiotic growth promoters influence human infections
145. Historical yearly usage of vancomycin
146. The epidemiology of intravenous vancomycin usage in a University hospital. A 10-year study
147. VanA-type glycopeptide resistant enterococci in Norway. Reservoirs - Transmission - Persistence
148. Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate
149. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City hospital
150. The Use of Antibiotics in Food-Producing Animals: Antibiotic-Resistant Bacteria in Animals and Humans
151. Vancomycin-resistant enterococci and use of avoparcin in animal feed: Is there a link?
152. Australia's antibiotic burden
153. Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria
154. Large conjugative vanA plasmids in vancomycin-resistant Enterococcus faecium
155. Mobilization of vancomycin resistance by transposon-mediated fusion of a VanA plasmid with an Enterococcus faecium sex pheromone-response plasmid
156. In vivo transfer of the vanA gene cluster in the intestinal tract of germfree animals
157. Transferability of macrolide, lincomycin, and streptogramin resistance between group A, B, and D streptococci, Streptococcus pneumoniae, and Staphylococcus aureus
158. Conjugative transfer of R-plasmids from Streptococcus faecalis to Staphylococcus aureus
159. Antimicrobial resistance in Staphylococcus aureus: Genetic basis
160. The life and times of the enterococcus
161. Streptococcus faecalis sex pheromone (cAM373) also produced by Staphylococcus aureus and identification of a conjugative transposon (Tn918)
162. Why does Staphylococcus aureus secrete an Enterococcus faecalis-specific pheromone?
163. Are glycopeptide-resistant enterococci in animals a threat to human beings?
164. Persistence of antibacterial agents in marine sediments
165. Degradation of the fluoroquinolone enrofloxacin by wood-rotting fungi
166. Structural modification of glycopeptide antibiotics
167. Degradation of ciprofloxacin by basidiomycetes and identification of metabolites by the brown rot fungus Gloephyllum striatum
168. Avoparcin and virginiamycin as animal growth promoters: A plea for science in decision-making
169. Will avilamycin convert Ziracine into Zerocine?
170. Antibiotics, animals, and people-again!
171. Casting pills before swine
172. The medical impact of the use of antimicrobials in food animals
173. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants
174. Molecular properties of bacterial multidrug transporters
175. Resistance gene capture
176. Integrons: Novel DNA elements which capture genes by site-specific recombination
177. An integron of class 1 is present on the plasmid pCG4 from Gram-positive bacterium Corynebacterium glutamicum
178. Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella enterica Typhimurium DT104
179. Characterisation of integrons and antibiotic resistance genes in Danish multiresistant Salmonella enterica Typhimurium DT104
180. Molecular characterization of an antibiotic resistance gene cluster in Salmonella typhimurium DT104